GeoVax Labs, Inc. (GOVX)Â
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
GOVX Insider Trading Activity
GOVX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $15,600 | 1 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| DODD DAVID A | President, CEO | 1 | $15,600 | 0 | $0 | $15,600 |
About GeoVax Labs, Inc.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
Insider Activity of GeoVax Labs, Inc.
Over the last 12 months, insiders at GeoVax Labs, Inc. have bought $15,600 and sold $0 worth of GeoVax Labs, Inc. stock.
On average, over the past 5 years, insiders at GeoVax Labs, Inc. have bought $46,191 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DODD DAVID A (President, CEO) — $15,600.
The last purchase of 8,000 shares for transaction amount of $15,600 was made by DODD DAVID A (President, CEO) on 2024‑08‑09.
List of Insider Buy and Sell Transactions, GeoVax Labs, Inc.
| 2024-08-09 | DODD DAVID A | President, CEO | 8,000 0.1589% | $1.95 | $15,600 | +19.25% | ||
| 2024-02-22 | DODD DAVID A | President, CEO | 8,209 0.431% | $2.27 | $18,663 | -3.42% | ||
| 2024-02-21 | DODD DAVID A | President, CEO | 520 0.0257% | $2.15 | $1,118 | -3.64% | ||
| 2024-02-07 | Reynolds Mark | CFO | 2,000 0.0718% | $2.77 | $5,540 | -15.89% | ||
| 2023-12-22 | McKee Kelly T. Jr. | Chief Medical Officer | 6,944 0.0257% | $0.36 | $2,500 | -58.12% | ||
| 2023-09-25 | McKee Kelly T. Jr. | Chief Medical Officer | 9,653 0.0371% | $0.52 | $5,020 | -63.43% | ||
| 2023-08-25 | DODD DAVID A | President, CEO | 35,087 0.1351% | $0.57 | $20,000 | -64.70% | ||
| 2023-08-18 | Reynolds Mark | CFO | 10,000 0.038% | $0.52 | $5,179 | -61.64% | ||
| 2023-04-24 | DODD DAVID A | President, CEO | 32,000 0.122% | $0.64 | $20,445 | -18.34% | ||
| 2023-04-20 | Reynolds Mark | CFO | 8,000 0.0297% | $0.63 | $5,040 | -19.13% | ||
| 2022-09-21 | CHASE RANDAL D | director | 10,000 0.043% | $1.10 | $11,000 | -39.45% | ||
| 2022-07-01 | Sharkey John W. | VP, Business Development | 1,000 0.0043% | $0.82 | $820 | -6.46% | ||
| 2022-06-27 | McKee Kelly T. Jr. | Chief Medical Officer | 4,464 0.0367% | $1.12 | $5,000 | -28.66% | ||
| 2022-06-21 | CHASE RANDAL D | 10,000 0.0761% | $1.21 | $12,100 | -38.29% | |||
| 2022-05-05 | McKee Kelly T. Jr. | Chief Medical Officer | 9,722 0.0758% | $0.72 | $7,000 | +11.57% | ||
| 2022-05-04 | McKee Kelly T. Jr. | Chief Medical Officer | 4,999 0.0362% | $0.71 | $3,549 | +5.19% | ||
| 2011-12-30 | ROBINSON HARRIET L | CSO Emeritus | 149,254 <0.0001% | $0.67 | $100,000 | |||
| 2011-12-30 | DODD DAVID A | President, CEO | 112,000 <0.0001% | $0.67 | $75,040 | |||
| 2011-12-30 | Reynolds Mark | CFO | 15,000 <0.0001% | $0.67 | $10,050 | |||
| 2010-07-02 | Reynolds Mark | CFO | 1,000 <0.0001% | $2.50 | $2,500 |
Insider Historical Profitability
| DODD DAVID A | President, CEO | 26661 0.2825% | $34,925.91 | 9 | 0 | <0.0001% |
| EMORY UNIVERSITY | 10 percent owner | 231070253 2448.7975% | $302.7M | 0 | 24 | |
| ROBINSON HARRIET L | CSO Emeritus | 1201226 12.7302% | $1.57M | 5 | 8 | |
| Tsolinas Peter M | director | 431734 4.5754% | $565,571.54 | 1 | 0 | |
| CHASE RANDAL D | director | 36613 0.388% | $47,963.03 | 2 | 0 | <0.0001% |
| McKee Kelly T. Jr. | Chief Medical Officer | 35782 0.3792% | $46,874.42 | 5 | 0 | <0.0001% |
| HILDEBRAND DONALD G | director | 19000 0.2014% | $24,890.00 | 1 | 0 | |
| SPENCER JOHN N JR | director | 13700 0.1452% | $17,947.00 | 4 | 0 | |
| MCNALLY ROBERT T | director | 8300 0.088% | $10,873.00 | 7 | 0 | |
| Reynolds Mark | CFO | 7213 0.0764% | $9,449.03 | 9 | 0 | <0.0001% |
| NEWMAN MARK J | Chief Scientific Officer | 3000 0.0318% | $3,930.00 | 1 | 0 | |
| Sharkey John W. | VP, Business Development | 2860 0.0303% | $3,746.60 | 1 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$8,253,997 | 122 | -53.40% | $12.32M | |
$992,222,850 | 90 | -12.52% | $12.4M | |
$1,724,269 | 63 | -16.36% | $12.18M | |
$8,900,811 | 57 | -24.79% | $13.53M | |
$1,226,605 | 43 | -21.28% | $9.76M | |
$383,884 | 32 | -25.10% | $13.89M | |
$95,303,339 | 30 | -13.78% | $12.59M | |
$112,810,270 | 18 | -1.20% | $13.39M | |
$86,569,038 | 18 | -12.64% | $11.53M | |
$114,371,781 | 18 | -1.31% | $12.97M | |
$29,469,413 | 18 | 30.38% | $12.99M | |
$490,284 | 15 | -19.03% | $10.39M | |
GeoVax Labs, Inc. (GOVX) | $122,973 | 15 | -26.96% | $12.36M |
$941,975 | 12 | -10.74% | $12.19M | |
$11,777,042 | 10 | -11.94% | $13.06M | |
$2,891,537 | 8 | -39.31% | $13.82M | |
$7,699,992 | 2 | -74.95% | $9.48M | |
$19,863 | 1 | 144.27% | $10.31M | |
$25,173 | 1 | -68.88% | $9.87M |
GOVX Institutional Investors: Active Positions
| Increased Positions | 12 | +54.55% | 179,745 | +40.02% |
| Decreased Positions | 9 | -40.91% | 339,121 | -75.51% |
| New Positions | 8 | New | 87,188 | New |
| Sold Out Positions | 7 | Sold Out | 331,890 | Sold Out |
| Total Postitions | 25 | +13.64% | 289,710 | -35.49% |
GOVX Ownership Change vs Market
Institutional Investor Ownership
| Geode Capital Management, Llc | $139.00 | 1% | 90,139 | +33,440 | +58.98% | 2024-12-31 |
| Vanguard Group Inc | $79.00 | 0.57% | 51,144 | +31,905 | +165.84% | 2024-12-31 |
| Citadel Advisors Llc | $65.00 | 0.47% | 42,275 | +42,275 | New | 2024-12-31 |
| Ubs Group Ag | $44.00 | 0.32% | 28,319 | +27,178 | +2,381.95% | 2024-12-31 |
| Blackrock, Inc. | $42.00 | 0.31% | 27,565 | 0 | 0% | 2024-12-31 |
| State Street Corp | $26.00 | 0.19% | 16,828 | +16,828 | New | 2024-12-31 |
| Engineers Gate Manager Lp | $18.00 | 0.13% | 11,936 | +11,936 | New | 2024-12-31 |
| Northern Trust Corp | $18.00 | 0.13% | 11,675 | +11,675 | New | 2024-12-31 |
| Citigroup Inc | $8.00 | 0.06% | 5,019 | -6,589 | -56.76% | 2024-12-31 |
| Summit Securities Group Llc | $5.00 | 0.03% | 3,000 | +3,000 | New | 2024-12-31 |